AFP and hepatocellular carcinoma: ,15 However, because 20%–30% of HCC tumors do not secrete AFP,29 future studies that combine relevant CpGs with AFP or other clinical diagnostic markers (eg, DCP) and genetic risk variants for multifactorial modeling could enhance prediction of HCC in patients with metabolic liver disease.